Transcriptional Co-activator p300 maintains basal hepatic gluconeogenesis

Journal of Biological Chemistry

Volumn 287, Issue 38, 2012, Pages 32069-32077

  He, Ling ^a   Naik, Karuna ^b   Meng, Shumei ^a   Cao, Jia ^a   Sidhaye, Aniket R ^a   Ma, Anlin ^a   Radovick, Sally ^a   Wondisford, Fredric E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GLUCOSE LEVEL; DIABETES MELLITUS; GLUCONEOGENIC GENES; GLUCOSE PRODUCTION; HEPATIC GLUCONEOGENESIS; MOUSE MODELS; PHOSPHORYLATION SITES; TRANSCRIPTIONAL CO-ACTIVATORS;

GENES; INSULIN; MAMMALS; PHOSPHORYLATION;

GLUCOSE;

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; GLUCOSE; INSULIN; PROTEIN P300;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HEPATIC GLUCONEOGENESIS; MOUSE; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HEPATOCYTES; INSULIN; LIVER; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; P300-CBP TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

MUS;

EID: 84866415671     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.385864     Document Type: Article

References (29)

1. Vannucci, R. C., and Vannucci, S. J. (2001) Hypoglycemic brain injury. Semin. Neonatol. 6, 147-155 (Pubitemid 32705985)
2. Desouza, C., Salazar, H., Cheong, B., Murgo, J., and Fonseca, V. (2003) Association ofhypoglycemia and cardiac ischemia: A study based on continuous monitoring. Diabetes Care 26, 1485-1489 (Pubitemid 36929183)
3. Einarsdóttir, A. B., and Stefánsson, E. (2009) Prevention of diabetic retinopathy. Lancet 373, 1316-1318
4. Bellentani, S., and Marino, M. (2009) Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann. Hepatol. 8, S4-8
5. Krebs, E. G. (1989) Role of the cyclic AMP-dependent protein kinase in signal transduction. JAMA 262, 1815-1818
6. Koo, S. H., Flechner, L., Qi, L., Zhang, X., Screaton, R. A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., Takemori, H., and Montminy, M. (2005) The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109-1111
7. He, L., Sabet, A., Djedjos, S., Miller, R., Sun, X., Hussain, M. A., Radovick, S., and Wondisford, F. E. (2009) Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell 137, 635-646
8. Goodman, R. H., and Smolik, S. (2000) CBP/ p300 in cell growth, transformation, and development. Genes Dev. 14, 1553-1577
9. Arany, Z., Sellers, W. R., Livingston, D. M., and Eckner, R. (1994) E1Aassociated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77, 799-800 (Pubitemid 24187678)
10. Yao, T. P., Oh, S. P., Fuchs, M., Zhou, N. D., Ch'ng, L. E., Newsome, D., Bronson, R. T., Li, E., Livingston, D. M., and Eckner, R. (1998) Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361-372 (Pubitemid 28232081)
11. Chan, H. M., and La Thangue, N. B. (2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114, 2363-2373 (Pubitemid 32684792)
12. Giandomenico, V., Simonsson, M., Grönroos, E., and Ericsson, J. (2003) Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Mol. Cell Biol. 23, 2587-2599 (Pubitemid 36351037)
13. Sundqvist, A., and Ericsson, J. (2003) Transcription-dependent degradation controls the stability of the SREBP family of transcription factors. Proc. Natl. Acad. Sci. 100, 13833-13838 (Pubitemid 37499152)
14. Kemper, J. K., Xiao, Z., Ponugoti, B., Miao, J., Fang, S., Kanamaluru, D., Tsang, S., Wu, S. Y., Chiang, C. M., and Veenstra, T. D. (2009) FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 10, 392-404
15. Qiang, L., Banks, A. S., and Accili, D. (2010) Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization. J. Biol. Chem. 285, 27396-27401
16. Petrij, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C., Masuno, M., Tommerup, N., van Ommen, G. J., Goodman, R. H., and Peters, D. J. (1995) Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature 376, 348-351
17. Wang, J., Weaver, I. C., Gauthier-Fisher, A., Wang, H., He, L., Yeomans, J., Wondisford, F., Kaplan, D. R., and Miller, F. D. (2010) CBP histone acetyltransferase activity regulates embryonic neural differentiation in the normal and Rubinstein-Taybi syndrome brain. Dev. Cell 18, 114-125
18. Iyer, N. G., Ozdag, H., and Caldas, C. (2004) p300/CBP and cancer. Oncogene 23, 4225-4231 (Pubitemid 38758588)
19. Zhou, X. Y., Shibusawa, N., Naik, K., Porras, D., Temple, K., Ou, H., Kaihara, K., Roe, M. W., Brady, M. J., and Wondisford, F. E. (2004) Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein. Nat. Med. 10, 633-637 (Pubitemid 38796855)
20. Liu, Y., Dentin, R., Chen, D., Hedrick, S., Ravnskjaer, K., Schenk, S., Milne, J., Meyers, D. J., Cole, P., Yates, J., 3rd, Olefsky, J., Guarente, L., and Montminy, M. (2008) A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 456, 269-273
21. De Guzman, R. N., Martinez-Yamout, M. A., Dyson, H. J., and Wright, P. E. (2004) Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites. J. Biol. Chem. 279, 3042-3049 (Pubitemid 38114297)
22. Bedford, D. C., Kasper, L. H., Wang, R., Chang, Y., Green, D. R., and Brindle, P. K. (2011) Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control. Cell Metab. 14, 219-230
23. Kang-Decker, N., Tong, C., Boussouar, F., Baker, D. J., Xu, W., Leontovich, A. A., Taylor, W. R., Brindle, P. K., and van Deursen, J. M. (2004) Loss of CBP causes T cell lymphomagenesis in synergy with p27(Kip1) insufficiency. Cancer Cell 5, 177-189 (Pubitemid 38283803)
24. Ramnanan, C. J., Edgerton, D. S., Rivera, N., Irimia-Dominguez, J., Farmer, B., Neal, D. W., Lautz, M., Donahue, E. P., Meyer, C. M., Roach, P. J., and Cherrington, A. D. (2010) Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo. Diabetes 59, 1302-1311
25. Boden, G., Cheung, P., Stein, T. P., Kresge, K., and Mozzoli, M. (2002) FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am. J. Physiol. Endocrinol. Metab. 283, E12-E19 (Pubitemid 34686662)
26. Adkins, A., Basu, R., Persson, M., Dicke, B., Shah, P., Vella, A., Schwenk, W. F., and Rizza, R. (2003) Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans. Diabetes 52, 2213-2220 (Pubitemid 37059490)
27. Nuttall, F. Q., Ngo, A., and Gannon, M. C. (2008) Regulation of hepatic glucose production and the role of gluconeogenesis in humans: Is the rate of gluconeogenesis constant? Diabetes Metab. Res. Rev. 24, 438-458
28. Bricambert, J., Miranda, J., Benhamed, F., Girard, J., Postic, C., and Dentin, R. (2010) Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J. Clin. Invest. 120, 4316-4331
29. Zhang, Y., Qiu, J., Wang, X., Zhang, Y., and Xia, M. (2011) AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300. Arterioscler. Thromb. Vasc. Biol. 31, 2897-2908